Lipigon Pharmaceuticals AB (LPGO.ST) Q3 2022 Earnings

24NovExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-1.09
-0.82
-0.56
-0.3

Details

Expected EPS
N/A
Actual EPS
-0.2964
Surprise EPS
-0.3
Surprise Percent
+∞%

Description

Lipigon Pharmaceuticals AB (LPGO.ST) has reported earnings of -0.2964 per share for Q3 2022.

0 Comments

Share your thoughts